Filiform Polyposis in Ulcerative Colitis: A Rare Pediatric Case

Nafiye Urgancı1, Derya Kalyoncu2,3, Canan Tanık4

  • 1Clinic of Pediatric Gastroenterology, İstanbul Şişli Hamidiye Etfal Training and Research Hospital, İstanbul, Turkey

Balkan Medical Journal
|April 25, 2018
PubMed

Insights

Filiform polyposis, a benign condition, can occur in children with ulcerative colitis, even during remission. This finding highlights the importance of recognizing these non-neoplastic polyps in pediatric inflammatory bowel disease.

Area of Science:

  • Gastroenterology
  • Pediatric Gastroenterology
  • Pathology

Background:

  • Filiform polyposis, also known as inflammatory or pseudopolyposis, is a rare, benign condition.
  • It arises from non-specific mucosal and submucosal reactions to severe inflammation, often associated with inflammatory bowel diseases like Crohn's disease and ulcerative colitis.
  • Characterized by multiple finger-like projections, it commonly affects the transverse and descending colon.

Observation:

  • A 15-year-old female patient with a history of ulcerative colitis presented with severe abdominal pain.
  • Imaging studies, including abdominal ultrasound and magnetic resonance enterography, indicated mucosal thickening in the transverse and descending colon.
  • Colonoscopy confirmed the presence of numerous small filiform polyps throughout the colon.

Findings:

  • Histopathological examination of the polyps revealed them to be inflammatory in nature.
  • These findings confirmed the association of filiform polyps with ulcerative colitis in this pediatric patient.
  • The polyps were determined to be non-neoplastic.

Implications:

  • This case demonstrates that non-neoplastic filiform polyps can be identified in pediatric patients with ulcerative colitis, even in periods of long-term remission.
  • The presence of filiform polyps may warrant further investigation or monitoring in pediatric patients with a history of inflammatory bowel disease.
  • Understanding this association is crucial for accurate diagnosis and management of pediatric inflammatory bowel disease and its complications.
Abstract

Related Concept Videos

Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
535
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.1K
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.2K
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
891
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
277
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
538